Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec(®), Gleevec™)

Tekijä Henkes, Martin, van der Kuip, Heiko, Aulitzky, Walter E
Julkaistu 2008

c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer: a retrospective study

Tekijä Fritz, Peter, Cabrera, Cristina M, Dippon, Jürgen, Gerteis, Andreas, Simon, Wolfgang, Aulitzky, Walter E, van der Kuip, Heiko
Julkaistu 2005

Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells

Tekijä Kleih, Markus, Böpple, Kathrin, Dong, Meng, Gaißler, Andrea, Heine, Simon, Olayioye, Monilola A., Aulitzky, Walter E., Essmann, Frank
Julkaisussa Cell Death Dis (2019)

Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts

Tekijä Haubeiss, Silke, Schmid, Jens O, Mürdter, Thomas E, Sonnenberg, Maike, Friedel, Godehard, van der Kuip, Heiko, Aulitzky, Walter E
Julkaistu 2010

p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin

Tekijä Gutekunst, Matthias, Oren, Moshe, Weilbacher, Andrea, Dengler, Michael A., Markwardt, Christiane, Thomale, Jürgen, Aulitzky, Walter E., van der Kuip, Heiko
Julkaistu 2011

Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA

Tekijä Heine, Simon, Kleih, Markus, Giménez, Neus, Böpple, Kathrin, Ott, German, Colomer, Dolors, Aulitzky, Walter E., van der Kuip, Heiko, Silkenstedt, Elisabeth
Julkaisussa J Hematol Oncol (2018)

Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast

Tekijä Sonnenberg, Maike, van der Kuip, Heiko, Haubeiß, Silke, Fritz, Peter, Schroth, Werner, Friedel, Godehard, Simon, Wolfgang, Mürdter, Thomas E, Aulitzky, Walter E
Julkaistu 2008

Short term culture of breast cancer tissues to study the activity of the anticancer drug taxol in an intact tumor environment

Tekijä van der Kuip, Heiko, Mürdter, Thomas E, Sonnenberg, Maike, McClellan, Monika, Gutzeit, Susanne, Gerteis, Andreas, Simon, Wolfgang, Fritz, Peter, Aulitzky, Walter E
Julkaistu 2006

Oncogenic Stress Induced by Acute Hyper-Activation of Bcr-Abl Leads to Cell Death upon Induction of Excessive Aerobic Glycolysis

Tekijä Dengler, Michael A., Staiger, Annette M., Gutekunst, Matthias, Hofmann, Ute, Doszczak, Malgorzata, Scheurich, Peter, Schwab, Matthias, Aulitzky, Walter E., van der Kuip, Heiko
Julkaistu 2011

The BCL-2 selective inhibitor ABT-199 sensitizes soft tissue sarcomas to proteasome inhibition by a concerted mechanism requiring BAX and NOXA

Tekijä Muenchow, Alina, Weller, Sandra, Hinterleitner, Clemens, Malenke, Elke, Bugl, Stefanie, Wirths, Stefan, Müller, Martin R., Schulze-Osthoff, Klaus, Aulitzky, Walter E., Kopp, Hans-Georg, Essmann, Frank
Julkaisussa Cell Death Dis (2020)

Notch1 signaling in NOTCH1-mutated mantle cell lymphoma depends on Delta-Like ligand 4 and is a potential target for specific antibody therapy

Tekijä Silkenstedt, Elisabeth, Arenas, Fabian, Colom-Sanmartí, Berta, Xargay-Torrent, Sílvia, Higashi, Morihiro, Giró, Ariadna, Rodriguez, Vanina, Fuentes, Patricia, Aulitzky, Walter E., van der Kuip, Heiko, Beà, Sílvia, Toribio, Maria L., Campo, Elias, López-Guerra, Mònica, Colomer, Dolors
Julkaisussa J Exp Clin Cancer Res (2019)